Atlas Trials

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

Clinical trial NCT02513498 · COMPLETED

Trial details

NCT number
NCT02513498
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Graft Versus Host Disease
Start date
2015-12-08
Primary completion
2018-01-05
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.